← back to search

Enitan D. Carrol

University of Liverpool · GB
Area of research
Epidemiology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Sepsis Diagnosis and Treatment, Neonatal and Maternal Infections, Pneumonia and Respiratory Infections, and Bacterial Infections and Vaccines.
h-index
44
citations
8,831
works
312
NIH funding
primary concept
Medicine
email

Recent publications

Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.
2026cited by 1position: contributordoi
From colonization to invasion: genomic and phenotypic comparison of faecal and bloodstream isolates from the same patients.
2026cited by 0position: contributordoi
Executive Summary: Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.
2026cited by 0position: contributordoi
Priorities for the development of a new rapid diagnostic test for patients with fever: a cross-sectional online survey among hospital physicians across Europe.
2026cited by 0position: contributordoi
Procalcitonin testing combined with NEWS2 evaluation compared with usual care based on NEWS2 for identification of sepsis and antibiotic initiation in the emergency department in England and Wales (PRONTO): a multicentre, randomised, controlled, open-label, phase 3 trial.
2026cited by 0position: contributordoi
Validating the PECARN rule to identify febrile infants at low risk of serious bacterial infections: an international validation study.
2026cited by 0position: contributordoi
MR-Pro-adrenomedullin (MR-proADM) and Host Immune Response Biomarkers Evaluation of procalcitonin-guided antibiotic duration in Children with Infection for Stratification of Effectiveness: the PRECISE Study
2026cited by 0position: contributor
Predicting trajectories of illness using RNA velocity of whole blood.
2026cited by 0position: contributordoi
MR-Pro-adrenomedullin (MR-proADM) and Host Immune Response Biomarkers Evaluation of procalcitonin-guided antibiotic duration in Children with Infection for Stratification of Effectiveness: the PRECISE Study
Efficacy and Mechanism Evaluation 2026cited by 0position: contributordoi
Procalcitonin-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection in the UK (BATCH): a pragmatic, multicentre, open-label, two-arm, individually randomised, controlled trial
The Lancet Child & Adolescent Health 2025cited by 13position: middledoi
The 2024 Phoenix Sepsis Score Criteria: Part 1, the Evolution in Definition of Sepsis and Septic Shock.
2025cited by 11position: contributordoi
A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatment.
2025cited by 9position: contributordoi
Immunity to <i>Streptococcus pyogenes</i> and Common Respiratory Viruses at Age 0 to 4 Years After COVID-19 Restrictions
JAMA Network Open 2025cited by 7position: middledoi
The 2024 Phoenix Sepsis Score Criteria: Part 4, What About Using World-Oriented Criteria?
2025cited by 7position: contributordoi
The value of white blood cell count in predicting serious bacterial infections in children presenting to the emergency department: a multicentre observational study.
2025cited by 7position: contributordoi
The 2024 Phoenix Sepsis Score Criteria: Part 5, What About "Parsimony" in the Criteria-Is Less Really More?
2025cited by 6position: contributordoi
Assessing children who are acutely ill in general practice using the National PEWS and LqSOFA clinical scores: a retrospective cohort study.
2025cited by 6position: contributordoi
Procalcitonin-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection in the UK (BATCH): a pragmatic, multicentre, open-label, two-arm, individually randomised, controlled trial.
2025cited by 5position: contributordoi
A 5-transcript signature for discriminating viral and bacterial etiology in pediatric pneumonia.
2025cited by 4position: contributordoi
Assessing the performance of paediatric early warning scores to predict critical deterioration events in hospitalised children (the DETECT study): a retrospective matched case-control study.
2025cited by 3position: contributordoi
Paediatric invasive group A streptococcal infections and associations with viral infections in 15 European countries after lifting non-pharmaceutical interventions against SARS-CoV-2: an interrupted time-series analysis.
2025cited by 2position: contributordoi
Host-response testing with MeMed BV in community-acquired pneumonia: an economic evaluation from the UK NHS perspective.
2025cited by 2position: contributordoi
Procalcitonin use in febrile children attending European emergency departments: a prospective multicenter study.
2025cited by 2position: contributordoi
Immunity to Streptococcus pyogenes and Common Respiratory Viruses at Age 0 to 4 Years After COVID-19 Restrictions.
2025cited by 2position: contributordoi
The authors reply.
2025cited by 1position: contributordoi
Effectiveness of biomarker-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection: the BATCH RCT.
2025cited by 1position: contributordoi
Correction: Metabolic response of Klebsiella oxytoca to ciprofloxacin exposure: a metabolomics approach.
2025cited by 0position: contributordoi
Procalcitonin in Pediatric Emergency Medicine.
2025cited by 0position: contributordoi
From Colonisation to Invasion: Genomic and Phenotypic Comparison of Faecal and Bloodstream Isolates from the same patients
2025cited by 0position: contributordoi
Coming in hot: using emotional journey maps to examine parental perceptions associated with presentation of their child with fever to the emergency department in England.
2025cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Michael Levin · All India Institute of Medical Sciences48 papers (2019–2025)Jethro A. Herberg · The London College44 papers (2019–2025)Luregn J. Schlapbach · The University of Queensland42 papers (2019–2025)Irene Rivero‐Calle · Universidade da Coruña38 papers (2021–2025)Federico Martinón-Torres · Hospital General Universitario Gregorio Marañón37 papers (2019–2026)Shunmay Yeung · University of London34 papers (2019–2026) · 25 papers (2019–2026)Victoria J. Wright · St Mary's Hospital21 papers (2020–2025)Mark Peters · Intensive Care National Audit & Research Centre16 papers (2020–2026)Andrew C. Argent · Red Cross War Memorial Children's Hospital15 papers (2020–2026)Niranjan Kissoon · BC Innovation Council14 papers (2020–2025)Adrienne G. Randolph · Murphy Oil Corporation (United States)14 papers (2020–2025)Saul N. Faust · University of Nottingham14 papers (2020–2026)Michael J. Carter · St. Mary's Hospital13 papers (2023–2026)Ulrich Von Both · MRC Unit the Gambia12 papers (2020–2025)Antonio Salas · Research Institute Hospital 12 de Octubre11 papers (2022–2025)Marieke Emonts · Newcastle upon Tyne Hospitals NHS Foundation Trust11 papers (2019–2025)Simon Nadel · Imperial College Healthcare NHS Trust10 papers (2020–2024)Philip Pallmann · Cardiff Metropolitan University10 papers (2021–2026)Henriette Moll · Sotiria General Hospital9 papers (2020–2026)